Guggenheim Capital LLC Pacific Biosciences Of California, Inc. Transaction History

Guggenheim Capital LLC

$12 Billion
Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 54,460 shares of PACB stock, worth $88,769. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,460

Previous 72,163 24.53%

Holding current value

$88,769

Previous $122,000 18.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$1.55 - $2.65 $27,439 - $46,912	-17,703 Reduced 24.53%	54,460 $99,000
Q3 2024 Nov 13, 2024	SELL	$1.2 - $2.17 $141,193 - $255,324	-117,661 Reduced 61.98%	72,163 $122,000
Q2 2024 Aug 14, 2024	SELL	$1.36 - $3.65 $51,274 - $137,612	-37,702 Reduced 16.57%	189,824 $260,000
Q1 2024 May 14, 2024	BUY	$3.52 - $9.59 $113,164 - $308,308	32,149 Added 16.45%	227,526 $853,000
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $256,835 - $445,697	43,021 Added 28.24%	195,377 $1.92 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $623,299 - $1.05 Million	-75,735 Reduced 33.2%	152,356 $1.27 Million
Q2 2023 Aug 11, 2023	SELL	$9.97 - $14.05 $351,871 - $495,866	-35,293 Reduced 13.4%	228,091 $3.03 Million
Q1 2023 May 10, 2023	SELL	$7.94 - $12.02 $142,221 - $215,302	-17,912 Reduced 6.37%	263,384 $3.05 Million
Q4 2022 Feb 14, 2023	SELL	$5.67 - $11.2 $201,574 - $398,171	-35,551 Reduced 11.22%	281,296 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $29,588 - $64,523	-7,529 Reduced 2.32%	316,847 $1.84 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $505,442 - $1.31 Million	-125,732 Reduced 27.93%	324,376 $1.43 Million
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $264,111 - $654,797	31,330 Added 7.48%	450,108 $4.1 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $1.56 Million - $2.44 Million	81,136 Added 24.03%	418,778 $8.57 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $8.24 Million - $11.6 Million	331,309 Added 5231.47%	337,642 $8.63 Million
Q2 2021 Aug 13, 2021	BUY	$22.3 - $36.02 $141,225 - $228,114	6,333 New	6,333 $221,000
Q4 2019 Feb 14, 2020	SELL	$4.6 - $5.57 $64,767 - $78,425	-14,080 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.99 - $6.16 $89,535 - $110,528	-17,943 Reduced 56.03%	14,080 $73,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $751 - $941	127 Added 0.4%	32,023 $194,000
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $216,892 - $236,030	31,896 New	31,896 $231,000

Others Institutions Holding PACB

# of Institutions

259

Shares Held

256M

Call Options Held

3.05M

Put Options Held

1.71M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $366M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Pacific Biosciences Of California, Inc. Transaction History